CSIMarket



Viewray Inc.  (VRAY)
Other Ticker:  
 

Viewray's Tangible Leverage Ratio

VRAY's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




VRAY Tangible Leverage Ratio (Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Tangible Equity Change 12.43 % -20.1 % -15.26 % -39.75 % 40.01 %
Y / Y Total Liabilities Change 9.32 % 4.39 % -1 % -1.91 % 8.77 %
Tangible Leverage Ratio MRQ 0.9 0.97 0.75 1.01 0.92
Overall Ranking # 892 # 0 # 1984 # 1479 # 1818
Seq. Tangible Equity Change 22.12 % -15.43 % 26.22 % -13.76 % -13.21 %
Seq. Total Liabilities Change 12.75 % 9.18 % -5.94 % -5.58 % 7.66 %



Tangible Leverage Ratio forth quarter 2021 Comment
In Spite of the net new borrowings of 12.75% Viewray managed to improve Tangible Leverage Ratio in the forth quarter 2021 to 0.9, below company's average Tangible Leverage Ratio.

Within Medical Equipment & Supplies industry in the forth quarter 2021, 70 other companies have achieved lower Tangible Leverage Ratio than Viewray. While Tangible Leverage Ratio total ranking has deteriorated compare to the previous quarter from 0 to 892.

Explain Tangible Leverage Ratio?
What is VRAY Market Share?
Tangible Leverage Ratio forth quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 71
Healthcare Sector # 269
Overall Market # 892


Tangible Leverage Ratio Statistics
High Average Low
56.02 4.68 0.59
(Dec 31 2017)   (Sep 30 2018)




Financial Statements
Viewray's Tangible Equity $ 170 Millions Visit VRAY's Balance sheet
Viewray's Total Liabilities $ 152 Millions Visit VRAY's Balance sheet
Source of VRAY's Sales Visit VRAY's Sales by Geography


Cumulative Viewray's Tangible Leverage Ratio

VRAY's Tangible Leverage Ratio for the trailling 12 Months

VRAY Tangible Leverage Ratio

(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Tangible Equity TTM Growth 12.43 % -20.1 % -15.26 % -39.75 % 40.01 %
Y / Y Total Liabilities TTM Growth 9.32 % 4.39 % -1 % -1.91 % 8.77 %
Tangible Leverage Ratio TTM 0.9 0.9 0.84 0.81 0.72
Total Ranking TTM # 1631 # 0 # 1453 # 768 # 1966
Seq. Tangible Equity TTM Growth 22.12 % -15.43 % 26.22 % -13.76 % -13.21 %
Seq. Total Liabilities TTM Growth 12.75 % 9.18 % -5.94 % -5.58 % 7.66 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Despite of the net new borrowings of 12.75% Viewray managed to unchange Tangible Leverage Ratio in IV. Quarter to 0.9, below Viewray's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 114 other companies have achieved lower Tangible Leverage Ratio than Viewray. While total ranking remained unchanged compare to previous quarter at no. 1631.

Explain Tangible Leverage Ratio?
What is VRAY Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 115
Healthcare Sector # 607
Within the Market # 1631


TTM Tangible Leverage Ratio Statistics
High Average Low
29.95 3.12 0.72
(Mar 31 2018)   (Sep 30 2020)




Companies with similar Tangible Leverage Ratio in the quarter ending Dec 31 2021, within Medical Equipment & Supplies Industry Tangible Leverage RatioDec 31 2021 MRQ Total LiabilitiesDec 31 2021 MRQ Tangible Equity
Glaukos Corp  2.46 $ 462.547  Millions$ 188.236  Millions
Newegg Commerce Inc   2.44 $ 444.300  Millions$ 182.282  Millions
Avinger Inc  2.03 $ 19.762  Millions$ 9.723  Millions
Vapotherm Inc.  1.94 $ 91.337  Millions$ 46.969  Millions
Resmed Inc.  1.93 $ 1,588.907  Millions$ 822.363  Millions
Tela Bio Inc.  1.93 $ 34.285  Millions$ 17.795  Millions
Escalon Medical Corp   1.84 $ 2.998  Millions$ 1.631  Millions
Cerus Corporation  1.84 $ 152.880  Millions$ 83.303  Millions
Delcath Systems Inc.  1.72 $ 20.549  Millions$ 11.952  Millions
Alector Inc.  1.71 $ 513.934  Millions$ 300.724  Millions
Harpoon Therapeutics Inc.  1.68 $ 97.382  Millions$ 58.070  Millions
Motus Gi Holdings Inc.  1.67 $ 16.125  Millions$ 9.657  Millions
Novocure Limited  1.61 $ 658.999  Millions$ 410.494  Millions
Angiodynamics Inc.  1.58 $ 103.741  Millions$ 65.659  Millions
Merit Medical Systems Inc  1.49 $ 597.827  Millions$ 401.225  Millions
Infusystem Holdings Inc  1.47 $ 49.314  Millions$ 33.632  Millions
Medpace Holdings Inc.  1.45 $ 362.366  Millions$ 249.172  Millions
Precision Biosciences Inc  1.35 $ 120.330  Millions$ 89.120  Millions
Biolase Inc.  1.35 $ 30.076  Millions$ 22.282  Millions
Iridex Corp  1.26 $ 25.388  Millions$ 20.129  Millions
Pear Therapeutics Inc.  1.18 $ 106.726  Millions$ 90.434  Millions
Dexcom Inc.  1.12 $ 2,490.900  Millions$ 2,225.000  Millions
X4 Pharmaceuticals Inc  1.10 $ 51.689  Millions$ 47.061  Millions
Universal Biosensors Inc.  1.10 $ 16.394  Millions$ 14.957  Millions
Plus Therapeutics Inc.  1.06 $ 11.034  Millions$ 10.413  Millions
Tandem Diabetes Care Inc.  1.03 $ 448.103  Millions$ 433.112  Millions
Avanos Medical Inc.  0.98 $ 316.000  Millions$ 321.100  Millions
Silk Road Medical Inc.  0.98 $ 77.385  Millions$ 79.240  Millions
Assure Holdings Corp.  0.93 $ 19.453  Millions$ 20.859  Millions
Dynatronics Corporation  0.92 $ 11.936  Millions$ 12.974  Millions

Date modified: 2022-08-04T12:59:14-04:00

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KEYS's Profile

Stock Price

KEYS's Financials

Business Description

Fundamentals

Charts & Quotes

KEYS's News

Suppliers

KEYS's Competitors

Customers & Markets

Economic Indicators

KEYS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071